Print（PDF/212KB） Mar. 03, 2026 Corporate

Sumitomo Pharma Announces Organizational Realignment and Changes in Executive Officers and Other Key Positions

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Toru Kimura) today announced the following organizational realignment and changes in Executive Officers and other key positions, effective April 1, 2026.

1. Organizational Realignment (effective April 1, 2026)

Corporate Departments

Corporate Communications is created.

2. Changes in Executive Officers

(1) Promotion (effective April 1, 2026)

Katsuhiko Nishida (currently Vice President, Head of Capital Region Sales Department)
Shunji Kobayashi (currently General Manager, Communications Dept., Sumitomo Chemical Co., Ltd.)

(2) Departing Executive Officers (effective March 31, 2026)

Kenji Ueno (currently Executive Officer)
Koji Yamazaki (currently Executive Officer)

(3) Changes in the Positions Assumed by Executive Officers (effective April 1, 2026)

Position as of April 1, 2026	Current position	Name
Representative Director, Executive Vice President Global Corporate Strategy; Global Finance Administration External Affairs; CorporateGovernance; Corporate Communications; IT Management & Data Analytics	Representative Director, Executive Vice President Global Corporate Strategy; Global Finance Administration External Affairs; Corporate Governance; IT Management & Data Analytics	Motoyuki Sakai
Executive Officer Business Development & Management	Executive Officer Business Development & Management; Corporate Regulatory Compliance & Quality Assurance Division Senior Vice President, Head of Corporate Regulatory Compliance & Quality Assurance DivisionDeputy Head of Japan Business Unit	Koichi Kozuki
Executive Officer Corporate Regulatory Compliance & Quality Assurance Division Senior Vice President, Head of Corporate Regulatory Compliance & Quality Assurance Division Deputy Head of Japan Business Unit	Executive Officer Senior Vice President, Deputy Head of Corporate Regulatory Compliance & Quality Assurance Division Senior Vice President, Deputy Head of Research and Development Division (Drug Discovery Research)	Isao Shimizu
Executive Officer Legal & Compliance; Intellectual Property Chief Corporate Officer Sumitomo Pharma America, Inc.	Executive Officer Legal & Compliance; Intellectual Property; Human Resources	Kimihiro Mizuno
Executive Officer Sales & Marketing Division Senior Vice President, Head of Sales & Marketing Division Deputy Head of Japan Business Unit	Vice President, Head of Capital Region Sales Department	Katsuhiko Nishida
Executive Officer Human Resources	General Manager, Communications Dept., Sumitomo Chemical Co., Ltd.	Shunji Kobayashi

3. Changes in Personnel (effective April 1, 2026)

Corporate Departments

Position as of April 1, 2026	Current position	Name
External Affairs; Corporate Governance; Corporate Communications; IT Management & Data Analytics Vice President, Head of External Affairs	External Affairs; Corporate Governance; IT Management & Data Analytics Vice President, Head of External Affairs	Tomokazu Nagano
Senior Officer, US Asset Lead and Lead for Tech Transfer and Strategic Partnerships Sumitomo Pharma America, Inc.	Officer, Regenerative and Cellular Medicine US Business Lead Sumitomo Pharma America，Inc．	Haruhisa Iguchi
Senior Officer, RPE Program Lead RACTHERA Co., Ltd. Regenerative and Cellular Medicine Office	Business Strategy (Research Planning) Officer RACTHERA Co., Ltd. Regenerative and Cellular Medicine Office	Kiyoko Bando
Vice President, Head of Corporate Communications	Sustainability / Global Health Officer, Corporate Governance	Megumi Maruyama

Research and Development (Division)

Position as of April 1, 2026	Current position	Name
Senior Vice President, Deputy Head of Research and Development (Division) （Drug Discovery） Vice President, Head of CNS Drug Discovery Research Unit	Vice President, Head of CNS Drug Discovery Research Unit	Takeo Ishiyama
Senior Vice President, Deputy Head of Research and Development (Division) (CMC)	Vice President, Head of Process R&D Unit	Nobuhisa Fukuda
Senior Fellow, Nonclinical Safety Strategy & Governance Lead Research and Development (Division)	Vice President, Head of Preclinical Research Unit	Izuru Miyawaki
Vice President, Head of Chemistry Research Unit	Director, R&D Strategy, Global Corporate Strategy	Kozo Yoshida
Vice President, Head of Preclinical Research Unit	Preclinical Research Unit Fellow, DMPK	Takao Watanabe
Vice President, Head of Process R&D Unit	Vice President, Head of Chemistry Research Unit	Katsunori Tsuboi
Vice President, Head of Formulation R&D Unit Senior Director, Formulation R&D Group I, Formulation R&D Unit	Senior Director, Formulation R&D Group I, Formulation R&D Unit	Yuki Tsushima

Sales & Marketing (Division)

Position as of April 1, 2026	Current position	Name
Vice President, Head of Product Marketing	Vice President, Head of CNS Sales Department I	Hiroshi Ogawa
Vice President, Head of CNS Sales Department I	Senior Vice President, Head of Commercial Division, Marubeni Pharmaceuticals (Suzhou) Co., Ltd. Senior Vice President, Marubeni Pharmaceuticals (China) Co., Ltd.	Ryosuke Mori
Vice President, Head of Capital Region Sales Department	Vice President, Head of Product Marketing	Yasutoshi Araki